The in vitro fertilization (IVF) market is expanding steadily as the global prevalence of infertility rises, particularly among individuals delaying childbirth due to career or personal priorities. The market includes conventional IVF, IVF with intracytoplasmic sperm injection (ICSI), and both fresh and frozen embryo transfer cycles. Fertility clinics are the primary providers, leveraging advanced reproductive technologies, including time‑lapse embryo imaging, AI-assisted embryo evaluation, and preimplantation genetic screening. Growth is driven by increasing infertility rates, improved awareness, innovations in assisted reproductive technologies, and expanding medical tourism for affordable treatment options. North America remains a leading market, while the Asia-Pacific region is emerging rapidly as a growth hub
According to Fortune Business Insights, the global in vitro fertilization (IVF) market size was valued at USD 16.89 billion in 2018 and is projected to reach USD 65.63 billion by 2032, exhibiting a CAGR of 10.2% during the forecast period. Europe dominated the IVF market with a market share of 44.82% in 2018.
Shady Grove Fertility recently announced the opening of a full-service IVF centre in Tampa, Florida—highlighting ongoing investment in fertility infrastructure .